215 related articles for article (PubMed ID: 12763090)
21. Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons.
Mailleux P; Vanderhaeghen JJ
Neurosci Lett; 1992 Dec; 148(1-2):173-6. PubMed ID: 1300492
[TBL] [Abstract][Full Text] [Related]
22. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
Glass M; Dragunow M; Faull RL
Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid CB(1) receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice.
González S; Mena MA; Lastres-Becker I; Serrano A; de Yébenes JG; Ramos JA; Fernández-Ruiz J
Brain Res; 2005 Jun; 1046(1-2):195-206. PubMed ID: 15882845
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of kainate receptors in the basal ganglia of the developing and adult rat brain.
Wüllner U; Standaert DG; Testa CM; Penney JB; Young AB
Brain Res; 1997 Sep; 768(1-2):215-23. PubMed ID: 9369318
[TBL] [Abstract][Full Text] [Related]
25. Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats.
Eberle-Wang K; Mikeladze Z; Uryu K; Chesselet MF
J Comp Neurol; 1997 Jul; 384(2):233-47. PubMed ID: 9215720
[TBL] [Abstract][Full Text] [Related]
26. Motor actions of cannabinoids in the basal ganglia output nuclei.
Sañudo-Peña MC; Tsou K; Walker JM
Life Sci; 1999; 65(6-7):703-13. PubMed ID: 10462071
[TBL] [Abstract][Full Text] [Related]
27. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease.
Di Marzo V; Hill MP; Bisogno T; Crossman AR; Brotchie JM
FASEB J; 2000 Jul; 14(10):1432-8. PubMed ID: 10877836
[TBL] [Abstract][Full Text] [Related]
28. Substantia nigra compacta neurons that innervate the reticular thalamic nucleus in the rat also project to striatum or globus pallidus: implications for abnormal motor behavior.
Anaya-Martinez V; Martinez-Marcos A; Martinez-Fong D; Aceves J; Erlij D
Neuroscience; 2006 Dec; 143(2):477-86. PubMed ID: 17008017
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia.
Testa CM; Friberg IK; Weiss SW; Standaert DG
J Comp Neurol; 1998 Jan; 390(1):5-19. PubMed ID: 9456172
[TBL] [Abstract][Full Text] [Related]
30. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence.
de Lago E; de Miguel R; Lastres-Becker I; Ramos JA; Fernández-Ruiz J
Brain Res; 2004 May; 1007(1-2):152-9. PubMed ID: 15064146
[TBL] [Abstract][Full Text] [Related]
31. The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.
Romero J; de Miguel R; Ramos JA; Fernández-Ruiz JJ
Life Sci; 1998; 62(4):351-63. PubMed ID: 9450507
[TBL] [Abstract][Full Text] [Related]
32. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
[TBL] [Abstract][Full Text] [Related]
33. Initial observations on the distribution of cannabinoid receptor binding sites in the human adult basal ganglia using autoradiography.
Mailleux P; Verslijpe M; Vanderhaeghen JJ
Neurosci Lett; 1992 May; 139(1):7-9. PubMed ID: 1407683
[TBL] [Abstract][Full Text] [Related]
34. Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study.
Mailleux P; Vanderhaeghen JJ
J Neurochem; 1993 Nov; 61(5):1705-12. PubMed ID: 7901331
[TBL] [Abstract][Full Text] [Related]
35. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.
Lastres-Becker I; de Miguel R; De Petrocellis L; Makriyannis A; Di Marzo V; Fernández-Ruiz J
J Neurochem; 2003 Mar; 84(5):1097-109. PubMed ID: 12603833
[TBL] [Abstract][Full Text] [Related]
36. Morphological and biochemical adaptations to unilateral dopamine denervation of the neostriatum in newborn rats.
Penit-Soria J; Durand C; Herve D; Besson MJ
Neuroscience; 1997 Apr; 77(3):753-66. PubMed ID: 9070750
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.
Tsou K; Brown S; Sañudo-Peña MC; Mackie K; Walker JM
Neuroscience; 1998 Mar; 83(2):393-411. PubMed ID: 9460749
[TBL] [Abstract][Full Text] [Related]
38. [Possible mechanism of cannabinoid-mediated modulation of signal transduction through the basal ganglia].
Sil'kis IG
Ross Fiziol Zh Im I M Sechenova; 2002 Feb; 88(2):144-57. PubMed ID: 11938644
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains.
Westlake TM; Howlett AC; Bonner TI; Matsuda LA; Herkenham M
Neuroscience; 1994 Dec; 63(3):637-52. PubMed ID: 7898667
[TBL] [Abstract][Full Text] [Related]
40. The neurobiology and evolution of cannabinoid signalling.
Elphick MR; Egertová M
Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
